#United States #Dallas #Akadeum Life Sciences #Alerion #Cell Separation

Akadeum's Groundbreaking Alerion™ Microbubble Cell Separation System

Akadeum Life Sciences® is set to make waves in the field of cell therapy with its innovative Alerion™ Microbubble Cell Separation System, which will be highlighted at Advanced Therapies Week (ATW) 2025. Scheduled from January 20-23 at the Kay Bailey Hutchinson Convention Center in Dallas, Texas, this event promises to be a hub of knowledge sharing and innovation for professionals in the cell therapy sector. Akadeum's early access program has already proven the Alerion™ system to be a game-changer, demonstrating the highest capacity, speed, and gentleness in cell isolation processes to date.

A Leap Forward in Cell Therapy Manufacturing

The early access program facilitated extensive testing of the Alerion™ system, resulting in unprecedented interest from cell therapy developers and clients. Requests for the system were received alongside a growing queue for two-to-three-week demonstrations. This response showcases the system’s potential to greatly enhance efficiency in cell therapy manufacturing.

Alerion™ can isolate up to 100 billion cells rapidly and gently, employing first-at-scale negative selection and depletion protocols. This addresses critical needs in maintaining high-quality, viable cells essential for effective therapeutic development. Traditional methods often fail to produce enough viable cells, which can derail therapy outcomes. By utilizing Akadeum's proprietary buoyant microbubble technology, the Alerion™ system solves these challenges, making it a valuable asset for manufacturers looking to improve their processes.

Engagement at Advanced Therapies Week

Akadeum is enthusiastic about engaging with innovators and leaders during ATW 2025. The company will offer various opportunities to learn more about the Alerion™ system at Booth #735. Attendees will be encouraged to join a demo waiting list, allowing them to experience firsthand how Akadeum differentiates itself with unparalleled support access across technical, regulatory, and engineering arenas.

Additionally, on January 23, Dr. Bill Lloyd, Senior Director of Research and Development, will present on improving CAR-T therapy workflows through microbubble technology. His presentation, titled "Improving CAR-T Therapy Workflows with Microbubbles: Fast, Large Scale Cell Isolation for Healthier Cells," will share data accrued from the beta and initial access programs, which have already engaged multiple cell therapy developers.

Nominee for Tech Disruptor of the Year

The performance of the Alerion™ system has not gone unnoticed, as Akadeum has been named a finalist for the Tech Disruptor of the Year Award. This prestigious recognition highlights technological innovations that meaningfully advance the realms of cell and gene therapy. Akadeum's commitment to exceptional technological advancement within the industry reinforces its status as a leader among innovators.

Join the Conversation

For those interested in diving deeper into the Alerion™ technology, an opportunity will be available to ask questions directly to Dr. Lloyd at Booth #735 on January 22. This “Ask the Engineer” session promises to be informative and is geared towards discussing the intricate details of Akadeum’s microbubble technology and its applications.

A Commitment to the Scientific Community

Akadeum Life Sciences has always prioritized its role in serving the scientific community by developing solutions that address persistent issues within cell therapy and related fields. The proprietary microbubble technology enables rapid workflow scaling and cell quality enhancement — aspects that are critical for the future of human health innovation.

The company’s ongoing partnerships with leading corporations and visionaries in the industry promise a brighter future for cell therapy, marked by faster, more accurate workflow solutions.

About Advanced Therapies Week

For over two decades, Advanced Therapies Week has been the premier event for the cell and gene therapy sector, facilitating collaboration and knowledge sharing among industry leaders and key stakeholders. Akadeum’s participation strengthens this community focus, helping propel transformative initiatives that improve patient outcomes in cell therapy.

In summary, as Akadeum showcases its breakthrough Alerion™ technology, the anticipation and excitement surrounding its potential contributions to cell therapy should not be underestimated. This event is a must-visit for those looking to stay at the forefront of innovation in this vital field.